RECRUITINGOBSERVATIONAL
Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
About This Trial
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.
Who May Be Eligible (Plain English)
* Who May Qualify:
1. Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
3. Aged ≥18 years at the index date.
- Exclusion Criteria History of lung transplantation surgery previously the baseline period
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
* Inclusion Criteria:
1. Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
3. Aged ≥18 years at the index date.
* Exclusion Criteria History of lung transplantation surgery previously the baseline period
Locations (1)
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, Argentina